CTEV · Claritev Corp
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Sep 23, 2024; bars on opposite sides are not compared.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Cash Conversion Ratio non-GAAP | 42% | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA non-GAAP | $302.71M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Free cash flow non-GAAP | -$37.96M | Six Months Ended June 30, 2026 | — |
| Unlevered Free Cash Flow non-GAAP | $126.25M | Six Months Ended June 30, 2026 | — |
| Claim charges processed | 179.8B | FY 2025 | — |
| Potential medical cost savings identified | 6.4B | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CTEV
this stock
Claritev Corp
|
$646.04M | -10.8% | +3.7% | — | 5.4% |
|
VEEV
Veeva Systems Inc
|
$39.60B | +9.2% | +28.1% | 43.2 | 4.5% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$14.08B | -18.8% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$12.21B | +64.8% | +28.2% | 37.4 | 4.2% |
|
TEM
Tempus AI, Inc.
|
$9.40B | -11.8% | +83.4% | — | 18.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Sep 23, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CTEV | +17.0% | +25.4% | +64.1% | +67.9% | -10.8% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +16.6% | +21.0% | +50.3% | +63.9% | -24.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.